One Stop Shop for All Your Market Research Reports

Global Hospital Injectable Drugs Market Size, Status and Forecast 2021-2027

Injectables refer to drug delivery system which acts as an alternative to oral drugs. As injectables are rapidly inserted into the human body using a syringe, they bypass the first-pass metabolism. In tablet form, some of the drugs become ineffective as they get dismantled in the stomach owing to the digestive enzymes. Generic injectables are pharmaceutical drugs that are bio-equivalent of a branded injectable in terms of dosage, strength, performance, intended use, side-effects and route of administration. In 2019, North America held the main share in global hospital injectable drugs market,with the propotion of 35%,Europe followed loosely ,at the propotion of 33%. Hospira (Pfizer Inc.) occupied the biggest global hospital injectable drugs market share(13%), Fresenius Kabi followed closely at the propotion of 13%, Baxter and Sichuan Kelun Pharmaceutical also played a virtal role in the market. Market Analysis and Insights: Global Hospital Injectable Drugs Market The global Hospital Injectable Drugs market size is projected to reach US$ 53540 million by 2027, from US$ 38660 million in 2020, at a CAGR of 4.8% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hospital Injectable Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hospital Injectable Drugs market in terms of revenue. On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hospital Injectable Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hospital Injectable Drugs market. Global Hospital Injectable Drugs Scope and Market Size Hospital Injectable Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hospital Injectable Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027. Segment by Type Generic Sterile Injectables Sterile Intravenous (IV) Solutions Segment by Application Oncology Anesthesia Anti-Infectives Parenteral Nutrition Cardiovascular Diseases By Region North America U.S. Canada Europe Germany France U.K. Italy Russia Nordic Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA By Company Hospira (Pfizer Inc.) Baxter Fresenius Kabi Sandoz (Novartis) Hikma Pharmaceuticals PLC Dr. Reddy’s Laboratories Ltd Grifols Nichi-Iko Group (Sagent) Teva Pharmaceutical Otsuka B.Braun JW Life Science Auromedics Sanofi Gland Pharma Endo International PLC Sichuan Kelun Pharmaceutical Cisen Pharmaceutical Shijiazhuang No. 4 Pharmaceutical Shandong Hualu Pharmaceutical CR Double-Crane
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Hospital Injectable Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Generic Sterile Injectables 1.2.3 Sterile Intravenous (IV) Solutions 1.3 Market by Application 1.3.1 Global Hospital Injectable Drugs Market Share by Application: 2016 VS 2021 VS 2027 1.3
Inquiry Before Buying

Request Sample

Share This Report

Our Clients

Payment Mode
Single User US $ 3900
Multi User US $5850
Corporate User US $7800
About this Report
Report ID 394668
Category
  • Pharmaceuticals and Healthcare
Published on 29-Nov
Number of Pages 129
Publisher Name QY Research
Editor Rating
★★★★★
★★★★★
(42)